CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 6.91: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.59%Below 5Y avg (4.91%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
33.3%Sustainable
Payback Period
59.3 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.85BCNY720.44M · vs all stocks (USD)
Trailing P/E
63.67xRevenue (TTM)
839.27MCNY124.65M · vs all stocks (USD)
Profit Margin
9.04%Beta
1.35xvs all stocks
52-Week Change
-0.11%vs all stocks
Market Capitalization
4.85BCNY720.44M · vs all stocks (USD)
Enterprise Value
4.57BCNY679.38M · vs all stocks (USD)
Trailing P/E
63.67xForward P/E
13.84xPrice to Sales (TTM)
5.84xPrice to Book (MRQ)
2.58xEnterprise to Revenue
5.45xEnterprise to EBITDA
31.29xGross Margin
60.99%Profit Margin
9.04%Operating Margin
16.63%Return on Assets (TTM)
2.06%Return on Equity (TTM)
4.16%Revenue (TTM)
839.27MCNY124.65M · vs all stocks (USD)
Revenue per Share (TTM)
1.65CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-28.90%Gross Profit (TTM)
440.34MCNY65.40M · vs all stocks (USD)
EBITDA (TTM)
93.48MCNY13.88M · vs all stocks (USD)
Net Income (TTM)
75.87MCNY11.27M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-18.40%Operating Cash Flow (TTM)
166.38MCNY24.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
42.65MCNY6.33M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.59%vs all stocks
5-Year Average Dividend Yield
4.91%vs all stocks
Payout Ratio
33.33%Revenue
924.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
419.51MCNYFY2025 · Dec 31, 2025Gross Profit
505.02MCNYFY2025 · Dec 31, 2025Operating Income
81.90MCNY12.16M · vs all stocks (USD)
Pre-tax Income
82.28MCNYFY2025 · Dec 31, 2025Income Tax Expense
613.25KCNYFY2025 · Dec 31, 2025Net Income
81.67MCNYFY2025 · Dec 31, 2025EBIT
86.52MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
156.10MCNYFY2025 · Dec 31, 2025Research & Development
44.41MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
285.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
13.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.78MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.23MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
81.67MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
148.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
69.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
125.64MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
81.67MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.77MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
45.81MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
17.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-79.35MCNYFY2025 · Dec 31, 2025Sale of Investments
795.56KCNYFY2025 · Dec 31, 2025Other Investing Activity
-210.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-288.55MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
618.95MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-889.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-24.91MCNYFY2025 · Dec 31, 2025Other Financing Charges
162.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-132.86MCNYFY2025 · Dec 31, 2025Shares Outstanding
513.31MSharesUpdated Aug 20, 2026Float Shares
296.07MSharesUpdated Aug 20, 2026% Held by Insiders
39.52%vs all stocks
% Held by Institutions
1.22%vs all stocks
Total Cash (MRQ)
365.33MCNY54.26M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7310CNYUpdated Aug 20, 2026Total Debt (MRQ)
288.58MCNY42.86M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1562xCurrent Ratio (MRQ)
2.01xBook Value per Share (MRQ)
3.70CNYUpdated Aug 20, 2026Total Assets
2.31BCNY343.29M · vs all stocks (USD)
Total Current Assets
857.60MCNYFY2025 · Dec 31, 2025Total Liabilities
489.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.45BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
35.63MCNYFY2025 · Dec 31, 2025Total Current Liabilities
454.33MCNYFY2025 · Dec 31, 2025Cash
125.64MCNYFY2025 · Dec 31, 2025Cash Equivalents
517.27KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
126.15MCNYFY2025 · Dec 31, 2025Other Short-term Investments
210.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
73.99MCNYFY2025 · Dec 31, 2025Inventory
237.63MCNYFY2025 · Dec 31, 2025Accounts Payable
68.63MCNYFY2025 · Dec 31, 2025Short-term Debt
263.54MCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.84MCNYFY2025 · Dec 31, 2025Common Stock (Book)
513.31MCNYFY2025 · Dec 31, 2025Retained Earnings
399.40MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.82BCNY270.52M · vs all stocks (USD)
Treasury Stock
101.19MCNYFY2025 · Dec 31, 202552-Week Low
7.66CNYUpdated Aug 20, 202652-Week High
15.21CNYUpdated Aug 20, 202652-Week Change
-0.11%vs all stocks
Beta
1.35xvs all stocks
50-Day MA
9.02CNYUpdated Aug 20, 2026200-Day MA
10.74CNYUpdated Aug 20, 2026Avg 10-Day Volume
21.27MSharesUpdated Aug 20, 2026Avg 30-Day Volume
26.75MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1500CNYUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.91: safe zoneNotable
Altman Z-Score: 6.91
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Beilu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Getein Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
SS Innovations International, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Wecome Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Immix Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Lifotronic Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
HD Hyundai Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPartial Recovery After Sharp DeclineMinimal Tax and Interest Drag
Guangdong Tecsun Science & Technology Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPartial Recovery After Sharp DeclineMinimal Tax and Interest Drag
Zhejiang Tailin Bioengineering Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPartial Recovery After Sharp DeclineMinimal Tax and Interest Drag